Yahoo Web Search

  1. Novartis' (NVS) Wet AMD Drug Beovu Obtains FDA Approval

    Zacks via Yahoo FinanceOct 09 15:10 PM

    Swiss pharma giant Novartis AG NVS announced that the FDA approved its ophthalmology drug Beovu (brolucizumab) injection for the treatment of wet age-related macular degeneration ...

  2. Novartis claims that this anti-VEGF therapy offers greater fluid resolution as compared to Regeneron/Bayer's market-leading drug Eylea.

  3. The recent FDA approval of Novartis AG’s NVS Beovu (brolucizumab) injection for the treatment of wet age-related macular degeneration (AMD) has put the spotlight on this promising space ...

  4. This week, the FDA approved Novartis' NVS potential blockbuster eye drug, Beovu. J&J JNJ submitted a regulatory application seeking label expansion approval of its plaque psoriasis drug, Stelara ...

  1. Ad
    related to Bayer Pharma AG